Literature DB >> 12677708

[Noninvasive intermittent self ventilation in chronic respiratory insufficiency].

O Karg1.   

Abstract

Corresponding to the two compartments of the respiratory system (lungs and ventilatory pump), two different forms of respiratory insufficiency can be distinguished on a pathophysiologic basis: disturbances of gas exchange with primary oxygenation failure (hypoxemia) due to pulmonary diseases and reduced ventilation of the lungs (hypoventilation) with primary elevated arterial carbon dioxide partial pressure (hypercapnia) and secondary hypoxemia due to disorders of the ventilatory pump. Different methods can be employed in the diagnosis of respiratory insufficiency, e.g., spirometry, blood gas analysis, nocturnal monitoring with capnography, or transcutaneous pCO2 registration and measurement of mouth occluding pressure. Therapeutic measures for respiratory insufficiency are based on two treatment principles: long-term oxygen therapy to improve hypoxemia and noninvasive ventilation therapy to improve hypercapnia and concomitant hypoxemia. The indication for long term ventilation depends on subjective complaints, objective measurement parameters, disease course, and other disease symptoms. The most frequent indications for home mechanical ventilation are diseases with restrictive ventilatory defects, especially chest wall disorders and neuromuscular disorders.

Entities:  

Mesh:

Year:  2003        PMID: 12677708     DOI: 10.1007/s00108-002-0817-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

1.  Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology.

Authors:  W G Bradley; F Anderson; M Bromberg; L Gutmann; Y Harati; M Ross; R G Miller
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

2.  A prospective study of quality of life in ALS patients treated with noninvasive ventilation.

Authors:  R A Lyall; N Donaldson; T Fleming; C Wood; I Newsom-Davis; M I Polkey; P N Leigh; J Moxham
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

3.  Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy.

Authors:  A K Simonds; F Muntoni; S Heather; S Fielding
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

4.  Noninvasive ventilation in acute respiratory failure--a meta-analysis update.

Authors:  John V Peter; John L Moran; Jennie Phillips-Hughes; David Warn
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

5.  The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study.

Authors:  I C Newsom-Davis; R A Lyall; P N Leigh; J Moxham; L H Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD.

Authors:  C Casanova; B R Celli; L Tost; E Soriano; J Abreu; V Velasco; F Santolaria
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

7.  Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency.

Authors:  P Leger; J M Bedicam; A Cornette; O Reybet-Degat; B Langevin; J M Polu; L Jeannin; D Robert
Journal:  Chest       Date:  1994-01       Impact factor: 9.410

8.  Long term non-invasive domiciliary assisted ventilation for respiratory failure following thoracoplasty.

Authors:  M Jackson; I Smith; M King; J Shneerson
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

9.  Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.

Authors:  D J Meecham Jones; E A Paul; P W Jones; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

10.  Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders.

Authors:  A K Simonds; M W Elliott
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.